Market Signal Briefing

Gemini AI Predicts XRP could approach $10, Cardano may climb toward $2.80, and Pepe has approached a retest of prior highs. Uptober has supported momentum, and expectations for U.S. policy updates and ETF decisions have guided risk appetite into late 2025.

Falcon Finance has secured a $10 million strategic investment from M2 Capital to advance its universal collateralization infrastructure for onchain liquidity and yield.

Companies

Breaking: Bybit Secures UAE Virtual Asset Platform Operator License with Confidence

TL;DR Bybit became the first cryptocurrency exchange to obtain the Virtual Asset Platform Operator License from the Securities and Commodities Authority (SCA) of the United

DeFi News

Aave V4 Unlocks Unified Liquidity for a Stronger DeFi Future

TL;DR Aave launched V4, a modular “hub-and-spoke” upgrade that eliminates liquidity fragmentation across the DeFi ecosystem. The model separates liquidity management from market logic, with

Solana News

Solana Faces Dramatic 50% Transaction Decline Sparking Bubble Concerns

TL;DR Solana’s daily transactions have plunged by nearly 50%, falling from 125 million in late July to roughly 64 million, even as SOL price rallied

Companies

PayPay strengthens Binance Japan with bold 40% stake deal

TL;DR Equity stake: PayPay acquired a 40% share in Binance Japan, linking its 70 million users with Binance’s blockchain expertise to accelerate mainstream crypto adoption

Markets

BTC and ETH are under pressure with $5.3B in options set to expire Friday

TL;DR Options expiry: $5.3B in BTC and ETH options expire Friday, with maximum pain at $117K for BTC and $4,400 for ETH. Market sentiment: Bitcoin

Featured

Coinbase Staking Unlocks New Opportunities for Investors in NYC

TL;DR New York Access: Coinbase staking is now live in New York, expanding availability to 46 states and signaling progress in a tightly regulated market.

Journalist

Posted: October 10, 2025

Key Takeaways
Why are investors confident in Bitcoin now?
Lower KC Fed Policy Uncertainty and $2.5 billion ETF inflows suggest trust in the Fed’s direction and stronger crypto risk appetite.

What do BTC on-chain signals reveal?
Binary CDD near 1 indicated that long-term holders were selling strategically as institutions accumulate, suggesting an early-stage accumulation phase before broader rallies.

Bitcoin [BTC] remains a risk asset that continues to act as a haven for investors during periods of economic uncertainty. Despite steady inflows, the asset traded near $122,000, up 0.57%, at press time, as steady inflows offset muted retail activity.

But could a stronger rally be next? AMBCrypto’s analysis suggests the probability remains high.

Economic uncertainty positions Bitcoin for a rally
Macroeconomic uncertainty in the U.S. market has positioned Bitcoin favorably for a potential rally.

This uncertainty is measured by the Kansas City Fed’s Policy Rate Uncertainty (KC PRU) index, which tracks short-term market uncertainty based on one-year interest rate forecasts.

The KC PRU has historically correlated closely with Bitcoin’s performance.

A decline in the index often signals reduced uncertainty, encouraging investors to allocate more capital to risk assets such as Bitcoin, the leading crypto asset with a $2 trillion market cap.

Source: Alphractal

In that context, data from Alphractal showed that previous periods of KC PRU decline, notably 2019–2021, coincided with strong BTC rallies. A similar setup has emerged between 2024 and early 2025, hinting at renewed upside momentum.

That macro backdrop aligns with on-chain accumulation trends.

Bitcoin accumulation on the rise
Bitcoin accumulation continued to strengthen, led by institutional investors.

Data from SoSoValue, which tracks ETF Inflows and Outflows, showed eight consecutive weekdays of inflows into Bitcoin totaling $2.5 billion.

The latest daily inflow reached $875 million, reflecting renewed conviction among large holders treating current prices as an accumulation zone.

Source: SoSoValue

Retail participation, on the other hand, has been more subdued.

According to CoinGlass, retail buyers added about $47 million worth of BTC during the same period. While smaller in scale, it still reflected a positive sentiment that aligned with the broader market tone.

Long-term holders maintain steady control
Broader accumulation strength is confirmed by the Accumulation/Distribution indicator, which climbed to 12.57 billion in volume, as of writing, marking strong capital retention.

To gauge whether investors are likely to hold or sell, we examined the Binary Coin Days Destroyed (CDD) metric. A reading of 1 suggests long-term holders are selling, while 0 indicates they are holding.

Source: CryptoQuant

Although the CDD primarily measures long-term holder activity, its influence often extends to the broader market. Sustained holding can boost confidence, while increased selling tends to trigger caution. However, there are nuances to note.

At press time, the metric hovered near 1, suggesting that long-term holders were selling their positions, yet institutions and retail were buying. This simply reflects stronger investor confidence, convinced of the potential upside in Bitcoin’s price.

, /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced today that over 81 percent of its Medicare Advantage (MA) members are in 2026 Medicare Advantage Prescription Drug (MAPD) plans that are rated 4 stars or higher (out of 5 stars) by the Centers for Medicare & Medicaid Services (CMS). Additionally, over 63 percent of Aetna Medicare Advantage members are in a 4.5-star plan for 2026.

"This year's Star Ratings reflect Aetna's strong fundamentals and unwavering commitment to delivering exceptional care experiences and better health outcomes for our Medicare Advantage members," said Aetna president Steve Nelson. "I am proud of the way our teams show up every day to support our members, enabling Aetna to serve as their trusted, reliable health care partner."

Aetna continues to be an industry leader in providing high-quality Medicare solutions, consistently ranking among the top tier of large publicly traded companies in CMS Star Ratings.

Our Star Ratings success includes high-quality performance for many of our largest MA contracts:

Our Aetna Life Insurance Company's H5522 contract, the primary contract serving over 1.3 million Employer Group Medicare Advantage members across the country, as well as serving 110 thousand Individual Medicare Advantage members in Pennsylvania, achieved 4.5 stars, extending its streak to 14 years with 4+ star performance.
Our Aetna Life Insurance Company's H5521 contract, serving 1.1 million Individual Medicare Advantage members in 33 states, once again achieved 4.5 stars repeating its performance from the prior year.
Our Aetna Health Inc. (PA)'s H3959 contract, with 210 thousand Individual Medicare Advantage members primarily in the states of Pennsylvania and Delaware, earned 4 stars.
Our SilverScript Insurance Company's H2293 contract, with 134 thousand Individual Medicare Advantage members in the states of Georgia and Texas, repeated a 4-star performance from its inaugural year.
Our Aetna Health Inc. (FL)'s H1609 contract, with 132 thousand Individual Medicare Advantage members in the states of Florida and Iowa, earned 4.5 stars, improving half a star year over year.
Our Coventry Health Care of Missouri, Inc.'s H2663 contract, with 128 thousand Individual Medicare Advantage members in the states of Missouri, Kansas, Illinois, Arkansas, and Oklahoma earned 4 stars, extending its streak to 14 years with 4+ star performance.

Every year, Medicare evaluates plans based on a 5-star rating system. The Star Ratings are posted at Medicare.gov. Visit AetnaMedicare.com to learn more about the 2026 Aetna Medicare plans. Or call 1-844-588-0041 (TTY: 711), 7 days a week, 8 AM to 8 PM. The Medicare Annual Enrollment Period runs from October 15 through December 7, 2025. A licensed agent may answer your call.

NOTE: Information in this release is based on 2026 Star Ratings data published by CMS on October 9, 2025, and MA and MAPD enrollment as of September 2025.

About CVS Health

CVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 87 million plan members. The Company also serves an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

About Aetna
Aetna, a CVS Health business, serves more than 37 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, and medical management capabilities, Medicaid health care management services, workers' compensation administrative services and health information technology products and services. Aetna's customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, visit Aetna.com.

Aetna Medicare is a HMO, PPO plan with a Medicare contract. Our SNPs also have contracts with State Medicaid programs. Enrollment in our plans depends on contract renewal. See Evidence of Coverage for a complete description of plan benefits, exclusions, limitations and conditions of coverage. Plan features and availability may vary by service area. 

To send a complaint to Aetna, call the Plan or the number on your member ID card. To send a complaint to Medicare, call 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week. If your complaint involves a broker or agent, be sure to include the name of the person when filing your grievance.

©2025 Aetna Inc.

Y0001_6161702_2026_M

Media contact
Phil Blando
[email protected]

Investor contact
Larry McGrath
800-201-0938
[email protected]

SOURCE CVS Health

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

October 09, 2025 5:28 PM EDT | Source: VIQ Solutions Inc.
Mississauga, Ontario--(Newsfile Corp. - October 9, 2025) - VIQ Solutions Inc. (TSX: VQS) ("VIQ", "VIQ Solutions" or the "Company"), a global provider of secure, AI-driven, digital voice and video capture technology and transcription services, is pleased to announce it has received conditional approval to list its common shares on the TSX Venture Exchange (the "TSXV"). In connection with the TSXV listing, the Company will voluntarily delist its common shares from the Toronto Stock Exchange (the "TSX").

The Company's management and Board of Directors have determined that this transition is in the best interests of VIQ. In arriving at this determination, the Company considered, among other things, the costs associated with a TSX listing versus a TSXV listing, its current market capitalization, the rules related to private placements and other forms of financing available to TSXV-listed issuers and the general suitability of a TSX listing versus a TSXV listing.

The Company expects to delist its common shares from the TSX on or about October 20, 2025 and list its common shares on the TSXV on or about October 21, 2025. The Company will remain a "reporting issuer" under applicable Canadian securities laws through the listing transition process. The Company will retain the trading symbol "VQS" once listed on the TSXV. Shareholder approval is not required under the policies of the TSX to proceed with the transition as the TSXV is an acceptable alternative market. No action is required by shareholders in connection with the transition of the Company's listing to the TSXV.

For more information about VIQ, please visit viqsolutions.com.

About VIQ Solutions

VIQ Solutions is a global provider of secure, AI-driven, digital voice and video capture technology and transcription services. VIQ offers a seamless, comprehensive solution suite that delivers intelligent automation, enhanced with human review, to drive transformation in the way content is captured, secured, and repurposed into actionable information. The cyber-secure, AI technology and services platform are implemented in the most rigid security environments including criminal justice, legal, insurance, government, corporate finance, media, and transcription service provider markets, enabling them to improve the quality and accessibility of evidence, to easily identify predictive insights and to achieve digital transformation faster and at a lower cost.

Forward-Looking Statements

Certain statements included in this press release constitute forward-looking statements or forward-looking information (collectively, "forward-looking statements") under applicable securities legislation. Such forward-looking statements or information are provided for the purpose of providing information about management's current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes.

Forward-looking statements typically contain statements with words such as "anticipate", "believe", "expect", "plan", "intend", "estimate", "propose", "project" or similar words, including negatives thereof, and suggest future outcomes or that certain events or conditions "may" or "will" occur. These statements are only predictions. Forward-looking statements in this press release include but are not limited to statements with respect to the proposed timing of the delisting and listing.

Forward-looking statements are based on several factors and assumptions which have been used to develop such statements, but which may prove to be incorrect. Although VIQ believes that the expectations reflected in such forward-looking statements are reasonable, undue reliance should not be placed on forward-looking statements because VIQ can give no assurance that such expectations will prove to be correct.

Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that while considered reasonable by the Company as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements, including but not limited to the factors described in greater detail in the "Risk Factors" section of the Company's annual information form and in the Company's other materials filed on SEDAR+ at www.sedarplus.ca.

These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. Such estimates and assumptions may prove to be incorrect or overstated. The forward-looking statements contained in this press release are made as of the date of this press release and the Company expressly disclaims any obligations to update or alter such statements, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/269912

LOS ANGELES--(BUSINESS WIRE)--Zoom Communications Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ZM.

, /PRNewswire/ -- Arthur J. Gallagher & Co. (NYSE: AJG) will release its third quarter 2025 earnings after the market closes on Thursday, October 30, 2025.  A printer-friendly format will be available on the company's website shortly thereafter.

In conjunction with this release, J. Patrick Gallagher, Jr., Chairman and CEO, will host a conference call on Thursday, October 30, 2025 at 5:30 pm ET/4:30 pm CT.

The conference call will be broadcast live through Gallagher's website at www.ajg.com and a conference call replay will be available on the company's website approximately two hours after the broadcast. The replay can be accessed by going to Investor Relations and clicking on Events & Presentations. 

Arthur J. Gallagher & Co. (NYSE: AJG), a global insurance brokerage, risk management and consulting services firm, is headquartered in Rolling Meadows, Illinois.  Gallagher provides these services in approximately 130 countries around the world through its owned operations and a network of correspondent brokers and consultants.

Contact:
Ray Iardella
VP - Investor Relations
(630) 285-3661 – [email protected]

SOURCE Arthur J. Gallagher & Co.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

Rapid advancements by artificial intelligence (AI) and soaring demand for that technology are creating a host of infrastructure demands. With that comes a set of new, potentially compelling investment opportunities.

For many investors, an ETF is the best way to play the increasingly interesting AI/infrastructure union. Enter the ALPS Electrification Infrastructure ETF (ELFY). ELFY, which debuted in April, follows the Ladenburg Thalmann Electrification Infrastructure Index. The rookie ETF focuses on companies with market values of at least $5 billion — a qualifier that could serve to reduce some of the risk associated with what’s still a novel investment concept.

Another advantage offered by ELFY is that it broadens the infrastructure opportunity set — one long reserved for well-heeled investors and participants in private markets — at a time when investor interest is surging. That surge is due in large part to innovative technologies such as AI and clean energy, among others.

“The broadening seems fitting, as infrastructure itself is central to everyday life ― from the utilities providing fuel to heat our homes, to the towers transmitting data for our mobile devices and the data centers powering the proliferation of AI,” according to BlackRock.

ELFY Jazzes Up Sleepy Sector Exposure
In some respects, ELFY is comparable to legacy infrastructure ETFs. For example, the ALPS fund allocates two-thirds of its weight to utilities and industrial stocks. Those aren’t glamorous sectors, but they’ve long been lynchpins of old guard infrastructure funds.

However, many of those old guard ETFs aren’t focusing on the industrial and utilities names that have significant exposure to new wave technologies. ELFY solves that problem, providing investors with an infrastructure mousetrap that could deliver better long-term returns.

“Among them: utilities providing electricity, water and gas for heating; oil and gas pipelines transporting fuel for our cars; airports, toll roads and railroads that are the gateways to business and leisure travel; tower companies that transmit our mobile data; and the data centers generating AI,” added BlackRock.

Proving that there’s a rock-solid case for the newly minted ELFY, Balfe Morrison, head of listed infrastructure strategies within BlackRock Fundamental Equities, noted that AI is in fact an “accelerator” for infrastructure investment. According to Morrison, it’s sensible for investors that are constructive on AI to hold similar views on infrastructure. In fact, infrastructure names with AI ties could prove durable even if AI-related earnings or spending suddenly retreat.

“So there is not going to be any earnings cliff or big earnings hit if the AI story is not what we all think it is,” observed Morrison.

For more news, information, and analysis, visit the ETF Building Blocks Content Hub.

Earn free CE credits and discover new strategies

Wall Street is taking a pause on Thursday as U.S. stocks and even the price of gold pull back from record highs following their torrid runs.

The S&P 500 slipped 0.2%, coming off its latest all-time high and its eighth gain in the last nine days. The Dow Jones Industrial Average was down 145 points, or 0.3%, as of noon Eastern time, and the Nasdaq composite was 0.2% lower.

Gold also fell following its stellar rally this year, while Treasury yields held relatively steady in the bond market. They’re taking a moment following big runs driven in large part by expectations that the Federal Reserve will cut interest rates to support the economy.

Financial markets have been so relentless, including a roughly 35% leap for the S&P 500 since a low in April, that worries are rising that stock prices may have shot too high and become too expensive. Concerns are particularly strong about the frenzy lifting stocks related to artificial-intelligence technology.

Subscribe to the Daily newsletter.Fast Company's trending stories delivered to you every day

Dell Technologies sank 5% for one of the market’s bigger losses, but that only trimmed its surge since talking up its AI growth opportunities earlier in the week. It’s still up 11% for the week so far.

Tesla was one of the heaviest weights on the market after falling 2%. The National Highway Traffic Safety Administration opened a preliminary evaluation of its “Full Self-Driving” system due to safety concerns.

Those losses helped offset a 4.9% ascent for Delta Air Lines, which reported a stronger profit for the summer than analysts expected.

Delta also gave a forecast for profit over the full year that topped analysts’ estimates. Its president, Glen Hauenstein, highlighted a broad-based acceleration in sales trends over the last six weeks, including for business travel domestically.

Such reports from companies are taking on more significance, offering windows into the strength of the economy. That’s because the U.S. government’s shutdown is delaying reports that would clearly show how the overall economy is doing. This is the second week where the U.S. government has not published its update on unemployment claims, for example, a report that usually guides Wall Street’s trading each Thursday.

PepsiCo rose 2.1% after it delivered a better profit for the latest quarter than analysts expected, saying momentum improved for its drinks business in North America. Delivering bigger profits is one of two ways that companies can make their stock prices look less expensive following their big rallies. The other is if their stock prices fall.

Akero Therapeutics leaped 16.7% after Novo Nordisk, the Danish maker of weight-loss drug Wegovy, said it would buy the South San Francisco-based drug developer. The price tag could reach $5.2 billion if Akero’s lead product candidate wins federal regulatory approval.

MP Materials, a company that mines and processes rare earths in California, rose 7.1% after China announced curbs on its exports of the materials, which are critical for the making of everything from consumer electronics to jet engines.

Costco Wholesale climbed 2.4% after the retailer said its revenue rose 8% in September from a year earlier.

In stock markets abroad, indexes were mixed in Europe after Italy’s Ferrari tumbled 14.1% following the release of financial forecasts that some analysts said were below their expectations.

Stocks in Shanghai leaped 1.3% after trading resumed there following a holiday.

Japan’s Nikkei 225 jumped 1.8% for another one of the world’s bigger moves. Technology giant SoftBank Group surged 11.4% after it announced a $5.4 billion deal to acquire the robotics unit of Swiss engineering firm ABB.

In the bond market, the yield on the 10-year Treasury held at 4.13%, where it was late Wednesday.

—Stan Choe, AP business writer

AP Writers Teresa Cerojano and Matt Ott contributed.

The extended deadline for Fast Company’s Most Innovative Companies Awards is this Friday, October 10, at 11:59 p.m. PT. Apply today.

Acquisition of high-quality portfolio centered on healthcare and life sciences investments

Accelerates strategy to diversify and optimize portfolio while adding significant scale

Enhances financial profile and is expected to be accretive to net investment income (“NII”)

MENLO PARK, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it has entered into a definitive merger agreement to acquire SWK Holdings Corporation (Nasdaq: SWKH) (“SWK”), a life science focused specialty finance company that provides minimally dilutive financing to small- and mid-sized commercial-stage healthcare companies.

Runway Growth’s Founder and CEO, David Spreng, said, “This transaction meaningfully advances our strategy to diversify and optimize our portfolio by adding SWK’s high-quality investments in the key sectors of healthcare and life sciences. At the same time, we are enhancing our earnings power, more than offsetting the anticipated loan repayments we previously signaled, and we expect to deliver mid-single-digit NII accretion. This transaction reinforces the strength of Runway Growth’s portfolio as we work to generate long-term value for our shareholders through disciplined growth and venture debt investing with a focus on excellent credit quality in the sectors we know best. Looking ahead, and with the full support of BC Partners Advisors L.P., we are pursuing growth through both organic and inorganic strategies as a permanent capital vehicle backed by the $10 billion BC Partners Credit platform. We are doing all of this while growing our shareholder base, improving our existing robust portfolio metrics and increasing our total assets to $1.3 billion pro forma with the SWK merger transaction.”

Key Transaction Highlights

Expands Position and Investment Capabilities in Healthcare and Life Sciences Sector – SWK’s focus on healthcare and life sciences will expand Runway Growth’s exposure in this large and growing market and Runway Growth Capital’s investment and deal sourcing teams with the addition of members from SWK’s healthcare and life sciences teams. Through this acquisition, the Company’s portfolio composition will change, increasing healthcare investments to approximately 31% of the portfolio from 14% as of June 30, 2025.Drives Portfolio Scale and Diversification Through High Quality Complementary Portfolio – The transaction will expand Runway Growth’s balance sheet to $1.3 billion in total assets pro forma for the SWK acquisition, while enhancing the Company’s already strong portfolio metrics through high quality investments in attractive verticals and a meaningful reduction in average loan size.1Positions Runway Growth to Execute on Organic and Inorganic Growth Strategies – This acquisition offers Runway Growth a repeatable blueprint, that is non-dilutive to shareholders, for future deals in the venture and growth investment ecosystem. The Company is bolstered by the support of the BC Partners Credit platform, which continues to enable and collaborate on both organic and inorganic strategies with the Runway Growth team.Enhances Runway Growth’s Financial Profile and Grows the Shareholder Base – The acquisition is expected to generate mid-single-digit run-rate NII accretion during the first full quarter following the transaction close, as well as drive improvements in dividend coverage and ROE, and expand Runway Growth’s pro-forma leverage ratio. Improvements in Runway Growth’s financial profile will increase the Company’s nominal leverage capacity and support continued risk-adjusted returns. Additionally, Runway Growth is broadening its shareholder base and the trading liquidity of common shares through merger terms, which include $75.5 million in Runway Growth shares to be issued to SWK’s shareholders. Additional Transaction Details

The transaction will be a net asset value (“NAV”)-for-NAV merger and will have an estimated purchase price of approximately $220 million, based on SWK’s June 30, 2025 reported financials and including estimated SWK transaction expenses. This includes a fixed stock component expected to total $75.5 million in Runway Growth shares valued at closing NAV per share and approximately $145 million in cash. The cash payment will be based on SWK’s final NAV, which will be struck 48 hours prior to closing and reflective of SWK’s accumulated retained earnings between June 30, 2025 and close. Additionally, Runway Growth Capital LLC, in its capacity as Runway Growth’s external investment adviser, will be contributing $9 million in cash for distribution as consideration to the stockholders of SWK separate from and in addition to the consideration described in the first sentence of this paragraph.

SWK’s portfolio includes 22 companies, with an approximate fair value of $242 million based on Runway Growth’s estimates conducted as of August 15, 2025.

SWK’s Board of Directors, which consists of three independent members, has unanimously approved the transaction. Carlson Capital L.P. has signed a Voting Agreement supporting the transaction. The transaction is expected to close in late 2025 or the first quarter of 2026, pending SWK shareholder and regulatory approvals and other customary closing conditions.

Advisors

Simpson Thacher & Bartlett LLP is serving as legal counsel to Runway Growth in connection with the transaction.

Keefe, Bruyette & Woods, A Stifel Company, is serving as lead financial advisor to SWK in connection with the transaction. Goodwin Procter serves as SWK’s legal counsel.

Conference Call

Runway Growth will hold a conference call to discuss the transaction at 8:00 a.m. PT (11:00 a.m. ET) on Friday, October 10, 2025. To participate in the conference call or webcast, participants should register online at the Runway Investor Relations website. The call can also be accessed through the following links:

Conference CallWebcast A replay of the webcast will be available two hours after the call and archived on the same web page for 90 days.

About Runway Growth Finance Corp.

Runway Growth is a specialty finance company focused on providing flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity. Runway Growth is a closed-end investment fund that has elected to be regulated as a business development company under the Investment Company Act of 1940. Runway Growth is externally managed by Runway Growth Capital LLC, an affiliate of BC Partners Advisors L.P. and led by industry veteran David Spreng. For more information, please visit www.runwaygrowth.com.

About SWK Holdings Corporation

SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. SWK provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. SWK’s unique financing structures provide flexible financing solutions at an attractive cost of capital to create long-term value for all SWK stakeholders. SWK’s solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million. For more information, please visit www.swkhold.com.

Forward-Looking Statements

Some of the statements in this press release may constitute forward-looking statements because they relate to future events, future performance or financial condition. The forward-looking statements may include statements as to future operating results of Runway and SWK, and distribution projections; business prospects of Runway and SWK, and the prospects of their portfolio companies; and the impact of the investments that Runway and SWK expect to make. In addition, words such as “anticipate,” “believe,” “expect,” “seek,” “plan,” “should,” “estimate,” “project” and “intend” indicate forward-looking statements, although not all forward-looking statements include these words. The forward-looking statements contained in this press release involve risks and uncertainties. Certain factors could cause actual results and conditions to differ materially from those projected, including the uncertainties associated with (i) the ability of the parties to consummate the merger on the expected timeline, or at all; (ii) the expected synergies and savings associated with the merger; (iii) the ability to realize the anticipated benefits of the merger, including the expected elimination of certain expenses and costs due to the merger; (iv) the impact of the merger on the depth of trading in Runway’s shares of common stock post-closing; (v) the possibility that any or all of the various conditions to the consummation of the merger may not be satisfied or waived; (vi) risks related to diverting management’s attention from ongoing business operations; (vii) the combined company’s plans, expectations, objectives and intentions; (viii) any potential termination of the merger agreement; (ix) the future operating results and net investment income projections of the combined company; (x) the ability of Runway Growth Capital LLC to implement its future plans with respect to the combined company; (xi) the ability of Runway Growth Capital LLC and its affiliates to attract and retain highly talented professionals; (xii) the business prospects of the combined company and the prospects of its portfolio companies; (xiii) the expected financings and investments and additional leverage that the combined company may seek to incur in the future; (xiv) the adequacy of the cash resources and working capital of the combined company; (xv) the risk that stockholder litigation in connection with the merger may result in significant costs of defense and liability. Runway has based the forward-looking statements included in this document on information available to it on the date hereof, and it assumes no obligation to update any such forward-looking statements; and (xvi) development programs for medical products, and the risks associated with the research and development of medical products. The development and commercialization of medical products involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Although Runway undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that it may make directly to you or through reports that it in the future may file with the SEC, including the Combined Proxy Statement and Prospectus (as defined below), annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

No Offer or Solicitation

This press release is not, and under no circumstances is it to be construed as, a prospectus or an advertisement and the communication of this press release is not, and under no circumstances is it to be construed as, an offer to sell or a solicitation of an offer to purchase any securities in Runway, SWK or in any fund or other investment vehicle managed by Runway Growth Capital LLC, BC Partners Advisors L.P. or any of their affiliates.

Additional Information and Where to Find It

This press release relates to the proposed merger and certain related matters (the “Proposals”). In connection with the Proposals, Runway will file with the SEC a proxy statement for SWK and a prospectus of Runway (the “Combined Proxy Statement and Prospectus”). The Combined Proxy Statement and Prospectus will contain important information about Runway, SWK and the Proposals. This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. SHAREHOLDERS OF SWK ARE URGED TO READ THE COMBINED PROXY STATEMENT AND PROSPECTUS, AND OTHER DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT Runway, SWK AND THE PROPOSALS. Investors and security holders will be able to obtain the documents filed with the SEC free of charge at the SEC’s website, http://www.sec.gov or, for documents filed by Runway, from Runway’s website at https://www.runwaygrowth.com, and, for documents filed by SWK, from SWK’s website at https://www.swkhold.com.

Participants in the Solicitation

Runway, its directors, certain of its executive officers and certain employees and officers of Runway Growth Capital LLC and its affiliates may be deemed to be participants in the solicitation of proxies in connection with the Proposals. Information about the directors and executive officers of Runway is set forth in its proxy statement for its 2025 Annual Meeting of Stockholders, which was filed with the SEC on April 29, 2025. SWK, its directors, certain of its executive officers and certain employees may be deemed to be participants in the solicitation of proxies in connection with the Proposals. Information about the directors and executive officers of SWK is set forth in the proxy statement for its 2025 Annual Meeting of Stockholders, which was filed with the SEC on April 29, 2025. Information regarding the persons who may, under the rules of the SEC, be considered participants in the solicitation of SWK shareholders in connection with the Proposals will be contained in the Combined Proxy Statement and Prospectus other relevant materials when such documents become available. These documents may be obtained free of charge from the sources indicated above.

IR Contacts

Taylor Donahue, Prosek Partners, [email protected]

Thomas B. Raterman, Chief Financial Officer and Chief Operating Officer, [email protected]

Combined total assets presented on a pro forma basis as of 6/30/25. Total assets, net of anticipated Runway Growth Q3’25 repayments, are estimated to be $1.2 billion.

, /PRNewswire/ -- Kaskela Law LLC announces that it is investigating the recently announced proposed buyout of Electronic Arts Inc. (NASDAQ: EA) ("EA" or the "Company") shareholders to determine whether the buyout agreement is fair to the Company's investors.

Click here for additional information:  https://kaskelalaw.com/case/electronic-arts/

On September 29, 2025, EA announced that it had agreed to be acquired by an investor consortium comprised of the Public Investment Fund of Saudi Arabia and other private equity firms at a price of $210.00 per share in cash. Following the closing of the proposed transaction, EA shareholders will be cashed out of their investment position and the Company's shares will no longer be publicly traded.

The investigation seeks to determine (i) whether $210.00 per share is sufficient monetary consideration for EA shares, and (ii) whether the Company's officers and/or directors breached their fiduciary duties or violated the securities laws in agreeing to sell the Company at $210.00 per share.

EA shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 to discuss their legal rights and options with respect to this transaction. Alternatively, investors may contact the firm by clicking on the following link (or by copying and pasting the link into your browser): 

https://kaskelalaw.com/case/electronic-arts/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis, which means that the firm's clients never pay any out-of-pocket costs for legal representation. For additional information about Kaskela Law LLC, including the firm's recent notable recoveries for investors, please visit www.kaskelalaw.com.

CONTACT:

Kaskela Law LLC 
D. Seamus Kaskela, Esq.
([email protected])
Adrienne Bell, Esq.
([email protected])
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
www.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.

SOURCE Kaskela Law LLC

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

By Reuters

October 9, 20259:56 PM UTCUpdated ago

CVS Health logo is seen in this illustration taken, February 11, 2025. REUTERS/Dado Ruvic/Illustration/File Photo Purchase Licensing Rights, opens new tab

CompaniesOct 9 (Reuters) - CVS Health

(CVS.N), opens new tab said on Thursday that its Aetna insurance business has over 81% of members in Medicare Advantage plans that are rated 4 stars or higher for 2026.

Additionally, over 63% of Aetna Medicare Advantage members are in a 4.5-star plan for next year, the company said.

Sign up here.

The U.S. Centers for Medicare & Medicaid Services, which is part of the HHS, issues star ratings for the plans — with five being the highest performing — to help beneficiaries choose among them.

The agency evaluates different factors to rate the plans, including customer satisfaction, access to care and performance on cancer screenings and management of chronic conditions, among others.

Medicare Advantage plans cover Americans aged 65 years and older.

Reporting by Sneha S K; Editing by Alan Barona

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired common stock of WPP plc (“WPP” or the “Company”) (NYSE: WPP) between February 27, 2025, to July 8, 2025, inclusive. You are hereby notified that the class action lawsuit Jack Marty v. WPP plc, et al. (Case No. 1:25-cv-08365) has been commenced in the United States District Court for the Southern District of New York. To get more information go to:

https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500. There is no cost or obligation to you.

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of WPP’s media arm; notably, that it was not truly equipped to handle the ongoing macroeconomic challenges while competing effectively and had instead begun to lose significant market share to its competitors.

On July 9, 2025, WPP published a trading update for the first half of 2025, alerting investors that the company had allegedly “seen a deterioration in performance as Q2 has progressed.” The Company attributed its misfortune to both “continued macro uncertainty weighing on client spend and weaker net new business than originally anticipated,” at least in part due to “some distraction to the business” as a result of the continued restructuring of WPP Media a.k.a. GroupM.

Following this news, the price of WPP’s common stock declined dramatically. From a closing market price of $35.82 per share on July 8, 2025, WPP’s stock price fell to $29.34 per share on July 9, 2025, a decline of about 18.1% in the span of just a single day.

If you suffered a loss in WPP common stock, you have until December 8, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP  
Joseph E. Levi, Esq. 
Ed Korsinsky, Esq. 
33 Whitehall Street, 27th Floor 
New York, NY 10004 
[email protected] 
Tel: (212) 363-7500 
Fax: (212) 363-7171 
www.zlk.com

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds V.F. Corporation (“VFC” or the “Company”) (NYSE:VFC) investors of the November 12, 2025 deadline to seek the role of lead plaintiff in a pending federal securities class action.

If you purchased or otherwise acquired V.F. Corporation securities, have information, or would like to learn more, please contact Thomas W. Elrod of Kirby McInerney LLP by email at [email protected], or fill out the form below, to discuss your rights or interests.

[CONTACT THE FIRM IF YOU SUFFERED A LOSS]

What Happened?

On May 21, 2025, VFC reported its fourth quarter and full-year fiscal 2025 results, highlighting a significant decline in growth trajectory for its Vans brand, which faltered from an 8% loss the quarter before to a 20% loss in the fourth quarter, and noting such decline would continue through the next quarter. The Company attributed its results and below-expectation guidance in part to deliberate actions by the Company to eliminate unprofitable or unproductive businesses and an additional set of deliberate actions already in-place but previously unannounced. VFC further noted that, disregarding these deliberate actions, Vans would still have shown a high single digit revenue decline, suggesting growth slowed in comparison to the prior year’s sequential improvements irrespective of managements new deliberate actions. On this news, the price of VFC shares declined by $2.28 per share, or approximately 15.8%, from $14.43 per share on May 20, 2025 to close at $12.15 on May 21, 2025.

What Is The Lawsuit About?

The lawsuit has been filed on behalf of investors who purchased securities during the period of October 30, 2023 through May 20, 2025, inclusive (“the Class Period”). The lawsuit alleges that defendants disseminated materially false and misleading statements and/or concealed material adverse facts concerning the true state of VFC’s turnaround plans; notably, that additional significant reset actions would be necessary to return the Vans brand to growth, resulting in significant setbacks to Vans revenue growth trajectory.

[CLICK HERE TO LEARN MORE ABOUT THE CLASS ACTION]

Why Kirby McInerney LLP
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1171
https://www.kmllp.com
[email protected]

Neogen (NEOG - Free Report) reported $209.19 million in revenue for the quarter ended August 2025, representing a year-over-year decline of 3.6%. EPS of $0.04 for the same period compares to $0.07 a year ago.

The reported revenue represents a surprise of +2.96% over the Zacks Consensus Estimate of $203.18 million. With the consensus EPS estimate being $0.05, the EPS surprise was -20%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Neogen performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenues- Food Safety- Natural Toxins & Allergens: $19.96 million versus $18.68 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -2% change.Revenues- Food Safety- Bacterial & General Sanitation: $41.65 million compared to the $38.7 million average estimate based on two analysts. The reported number represents a change of +4.4% year over year.Revenues- Food Safety- Indicator Testing, Culture Media & Other: $79.09 million versus $76.43 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -3.2% change.Revenues- Animal Safety- Life Sciences: $1.86 million versus the two-analyst average estimate of $1.82 million. The reported number represents a year-over-year change of +7.3%.Revenues- Animal Safety- Animal Care & Other: $7.58 million versus $8.16 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +13.5% change.Revenues- Animal Safety: $57.14 million versus the two-analyst average estimate of $54.65 million. The reported number represents a year-over-year change of -0.8%.Revenues- Food Safety: $152.05 million versus $146.62 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -4.6% change.Revenues- Animal Safety- Genomics Services: $16.57 million versus the two-analyst average estimate of $4.42 million. The reported number represents a year-over-year change of +4.3%.Revenues- Food Safety- Genomics Services: $5.56 million compared to the $13.26 million average estimate based on two analysts. The reported number represents a change of -0.6% year over year.Revenues- Animal Safety- Veterinary Instruments & Disposables: $11.91 million compared to the $13.94 million average estimate based on two analysts. The reported number represents a change of -4.9% year over year.View all Key Company Metrics for Neogen here>>>

Shares of Neogen have returned +4.1% over the past month versus the Zacks S&P 500 composite's +4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Total Upsized Offering of C$60 Million

October 09, 2025 16:55 ET

 | Source:

Osisko Development Corp.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

MONTREAL, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") is pleased to announce that, as a result of excess demand, it has entered into an amending agreement with National Bank Financial Inc., BMO Capital Markets and RBC Capital Markets, acting as co-lead underwriters and co-bookrunners (collectively, the "Underwriters"), to increase the size of its previously announced "bought deal" financing to C$60 million (the "Amendment").

LIFE Offering

As a result of the Amendment, Osisko Development will now issue three tranches of shares pursuant to the LIFE Exemption (as defined herein) for aggregate gross proceeds of C$49,999,980 (the "LIFE Offering"), as follows:

National Flow-Through Shares: 2,990,000 common shares of the Company (the "FT Shares") that will qualify as "flow-through shares" within the meaning of subsection 66(15) of the Income Tax Act (Canada) (the "Tax Act") at a price of C$6.69 per FT Share for gross proceeds of C$20,003,100;
British Columbia Flow-Through Shares: 1,444,000 common shares of the Company to certain eligible British Columbia resident subscribers (the "BC FT Shares", and together with the FT Shares, the "Flow-Through Shares") that will qualify as "flow-through shares" within the meaning of subsection 66(15) of the Tax Act at a price of C$6.93 per BC FT Share for gross proceeds of C$10,006,920; and
Common Shares: 4,182,000 common shares of the Company (the "Common Shares") at a price of C$4.78 per Common Share for gross proceeds of C$19,989,960.
Concurrent Private Placement

As a result of the Amendment, Osisko Development will also complete a concurrent "bought deal" private placement of 2,092,100 Common Shares at a price of C$4.78 per Common Share for gross proceeds of C$10,000,238 (the "Concurrent Private Placement").

The Company intends to use the net proceeds of the Common Shares issued pursuant to the LIFE Offering and Concurrent Private Placement, being approximately C$30 million, to contribute to the capital required to construct the Cariboo Gold Project and related pre-construction activities.

In all other respects, the terms of the LIFE Offering, including the use of proceeds of the Flow-Through Shares, will remain as previously disclosed in the original news release of the Company dated October 8, 2025 and entitled "Osisko Development Announces C$30 Million Bought Deal LIFE Offering of National and BC Flow-Through Shares" (the "Launch Release").

Closing of the LIFE Offering and the Concurrent Private Placement are expected to occur on the same date, being on or about October 29, 2025 (the "Closing Date"), and remain subject to certain conditions including, but not limited to, the receipt of all necessary regulatory approvals, including the conditional approval of the TSX Venture Exchange and the New York Stock Exchange. Notwithstanding the foregoing, the Closing Date must occur no later than the 45th day following the date of the Launch Release on October 8, 2025.

The LIFE Offering will be made pursuant to the listed issuer financing exemption available under Part 5A of National Instrument 45-106 – Prospectus Exemptions ("NI 45-106"), as amended by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the "LIFE Exemption") in each of the provinces and territories of Canada. The Common Shares under the LIFE Offering may also be offered, and the Flow-Through Shares may also be offered (or re-offered), in such offshore jurisdictions as may be agreed to by the Company and the Underwriters pursuant to available prospectus or registration exemptions in accordance with applicable laws provided that no prospectus filing or comparable obligation arises in connection with the sale of the Common Shares or the Flow-Through Shares in such other jurisdiction. The Common Shares and the Flow-Through Shares issued under the LIFE Exemption will not be subject to a statutory hold period pursuant to applicable Canadian securities laws.

The Concurrent Private Placement will be conducted on a private placement basis pursuant to available exemptions under NI 45-106, other than the LIFE Exemption, in each of the provinces and territories of Canada, and in such offshore jurisdictions as may be agreed to by the Company and the Underwriters pursuant to available prospectus or registration exemptions in accordance with applicable laws provided that no prospectus filing or comparable obligation arises in connection with the sale of the Common Shares in such other jurisdiction. The Common Shares issued under the Concurrent Private Placement will be subject to a statutory hold period of four months and one day pursuant to applicable Canadian securities laws.

An amended and restated offering document (the "Offering Document") relating to the LIFE Offering will be available to be accessed on SEDAR+ (www.sedarplus.ca) under Osisko Development's issuer profile and on the Company's website at https://osiskodev.com/. Prospective investors should read the Offering Document before making an investment decision.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or any U.S. state securities laws, and may not be offered or sold in the United States absent registration under the U.S. Securities Act and all applicable U.S. state securities laws or in compliance with an exemption therefrom.

ABOUT OSISKO DEVELOPMENT CORP.

Osisko Development Corp. is a continental North American gold development company focused on past-producing mining camps located in mining friendly jurisdictions with district scale potential. The Company's objective is to become an intermediate gold producer by advancing its flagship permitted 100%-owned Cariboo Gold Project, located in central B.C., Canada. Its project pipeline is complemented by the Tintic Project in the historic East Tintic mining district in Utah, U.S.A., and the San Antonio Gold Project in Sonora, Mexico—brownfield properties with significant exploration potential, extensive historical mining data, access to existing infrastructure and skilled labour. The Company's strategy is to develop attractive, long-life, socially and environmentally responsible mining assets, while minimizing exposure to development risk and growing mineral resources.

For further information, visit our website at www.osiskodev.com or contact:

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking information" (within the meaning of applicable Canadian securities laws) and "forward- looking statements" (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as "anticipate", "believe", "expect", "plan", "intend", "potential", "estimate", "propose", "project", "outlook", "foresee" or similar words suggesting future outcomes or statements regarding any potential outcome. Such statements in this news release may include, without limitation, statements pertaining to: the size of the Offering and the Concurrent Private Placement, the use of the net proceeds from the Offering and the Concurrent Private Placement, the closing of the Offering and the Concurrent Private Placement, the tax treatment of the Flow-Through Shares, the timing and ability of the Company to renounce the Qualifying Expenditures and the ability to obtain the necessary regulatory authority approvals. Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Actual results could differ materially due to a number of factors, including, without limitation, marketing of the Offering and the Concurrent Private Placement, and satisfying the conditions of closing of the Offering and the Concurrent Private Placement, including the requirements of the New York Stock Exchange and the TSX Venture Exchange (if at all). Although the Company believes that the expectations reflected in the forward-looking information or statements are reasonable, prospective investors in the Company securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise this forward-looking information and statements except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

Richelieu Hardware Ltd. (TSX:RCH:CA) Q3 2025 Earnings Call October 9, 2025 2:30 PM EDT

Company Participants

Richard Lord - CEO, President & Executive Director
Antoine Auclair - CFO & COO

Conference Call Participants

Hamir Patel - CIBC Capital Markets, Research Division
Zachary Evershed - National Bank Financial, Inc., Research Division

Presentation

Operator

Good afternoon, ladies and gentlemen, and welcome to the Richelieu Hardware Third Quarter Results Conference Call. [Operator Instructions]

Also note that this call is being recorded on October 9, 2025. [Foreign Language].

Richard Lord
CEO, President & Executive Director

Thank you. Good afternoon, ladies and gentlemen, and welcome to Richelieu's conference call for the third quarter and first 9 months ended August 31, 2025. With me is Antoine Auclair, CFO and COO. As usual, note that some of today's issue include forward-looking information, which is provided with the usual disclaimer, as reported in our financial filings.

We had a good third quarter with solid growth and expansion. All our results are on the rise, and we successfully pursued our acquisition strategy, closing 2 additional acquisitions following the quarter.

Except for Ontario, all our market segments in Canada and the U.S. performed well, driving our total sales up 6.7%. Our sales in Canada increased by 2.9%, while in the U.S., they rose by 11.4% in U.S. dollar, accounting for 45% of total sales for the quarter. Sales climbed 6.5% in the manufacturer market and 8.6% in the retailers and renovation superstore market. Our margins improved slightly with EBITDA margin of 11.4% and diluted net earnings per share increased by 4.9% to $0.43.

I would also point out that our operations generated cash flows of $82.7 million in the third quarter. This includes a $16.2 million reduction in inventories. We ended the period with a positive cash position of $12 million and a working capital

Recommended For You

, /PRNewswire/ -- Equity LifeStyle Properties, Inc. (NYSE: ELS) (referred to herein as the "Company," "we," "us," and "our") announced today that the Company's third quarter 2025 earnings will be released on Wednesday, October 22, 2025 after market close. The Company's executive management team will host a conference call and audio webcast on Thursday, October 23, 2025 at 11:00 a.m. Eastern Time to discuss the Company's operating and financial results.

The live audio webcast and replay of the conference call will be available on our website at www.equitylifestyleproperties.com in the Investor Relations section under Events.

Research analysts and other interested parties who wish to participate in the conference call must register through this link at least fifteen minutes prior to the scheduled start of the call to receive the dial-in details.

This press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. When used, words such as "anticipate," "expect," "believe," "project," "intend," "may be" and "will be" and similar words or phrases, or the negative thereof, unless the context requires otherwise, are intended to identify forward-looking statements and may include, without limitation, information regarding our expectations, goals or intentions regarding the future, and the expected effect of our acquisitions. Forward-looking statements, by their nature, involve estimates, projections, goals, forecasts and assumptions and are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those expressed in a forward-looking statement due to a number of factors, which include, but are not limited to the following: (i) the mix of site usage within the portfolio; (ii) yield management on our short-term resort and marina sites; (iii) scheduled or implemented rate increases on community, resort and marina sites; (iv) scheduled or implemented rate increases in annual payments under membership subscriptions; (v) occupancy changes; (vi) our ability to attract and retain membership customers; (vii) change in customer demand regarding travel and outdoor vacation destinations; (viii) our ability to manage expenses in an inflationary environment, including the impact of changes in tariffs, as well as costs associated with supply chain disruptions; (ix) changes in debt service and interest rates; (x) our ability to integrate and operate recent acquisitions in accordance with our estimates; (xi) our ability to execute expansion/development opportunities in the face of changes impacting the supply chain or labor markets; (xii) completion of pending transactions in their entirety and on assumed schedule; (xiii) our ability to attract and retain property employees, particularly seasonal employees; (xiv) ongoing legal matters and related fees; (xv) costs to clean up and restore property operations and potential revenue losses following storms or other unplanned events; and (xvi) the potential impact of material weaknesses, if any, in our internal control over financial reporting.

For further information on these and other factors that could impact us and the statements contained herein, refer to our filings with the Securities and Exchange Commission, including the "Risk Factors" and "Forward-Looking Statements" sections in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q.

These forward-looking statements are based on management's present expectations and beliefs about future events. As with any projection or forecast, these statements are inherently susceptible to uncertainty and changes in circumstances. We are under no obligation to, and expressly disclaim any obligation to, update or alter our forward-looking statements whether as a result of such changes, new information, subsequent events or otherwise.

We are a fully integrated owner of lifestyle-oriented properties and own or have an interest in 455 properties located predominantly in the United States consisting of 173,340 sites as of July 21, 2025. We are a self-administered, self-managed, real estate investment trust with headquarters in Chicago.

SOURCE Equity Lifestyle Properties, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

TORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced that Novari Health (“Novari”), a VitalHub company, has been commissioned for its first UK deployment with the South West Provider Collaborative for its electronic referral and bed management workflow solution. The deployment will expand Novari’s geographic footprint beyond current implementations in Canada and Australia.

The South West Provider Collaborative is a National Health Service (“NHS”)-led partnership of hospitals providing specialized mental health services for over 5.5 million people across the UK’s South West. The Novari technology will be used across four service lines: Child and Adolescent Mental Health Services, Adult Eating Disorders, Inpatient Perinatal Services, and Secure Mental Illness Services. The Novari Mental Health solution will manage regional referrals, mental health bed capacity and patient flow, ensuring patients receive timely care from the most appropriate provider, as close to home as possible.

Purpose-built for mental health, the technology provides real-time bed visibility, structured admission and transfer workflows, central intake, wait list management, and flexible routing to keep patients in-region whenever possible. Novari’s Mental Health solution ensures complete and appropriate referrals through configurable triage and workflow tracking, standard intake from all sources, and real-time region-wide dashboards for oversight. Proven globally in regional deployments, the technology is scalable, integrated, and supports comprehensive flow management across sites, services, and bed states. This streamlines the process, enabling better communication among providers, and helps to reduce wait times and improve access to care.

Novari technology also includes optional AI enhanced analytics that provide real-time data on patient waiting times, helping organizations enhance resource utilization, identify workflow bottlenecks, and improve operational efficiency.

“As a specialized mental healthcare commissioner delivering patient-centred care across an extensive geographical area, it’s vital that we can manage the patient journey from referral to assessment to admission. The ability to access real-time bed availability at a regional or unit level means we can optimize bed usage, report on activity and address system pressure points. We can also identify any urgent referrals and prioritize patient care according to need,” said Dr. Jason Fee, Medical Director, South West Provider Collaborative.

“Ensuring people can access the mental health services they need, when they need them, is one of the defining healthcare challenges of our era. It is deeply rewarding to see our technology helping organizations across the UK, Australia, and Canada make meaningful progress on this front,” said John Sinclair, CPHIMS-CA, President & CEO, Novari Health.

About the South West Provider Collaborative

The South West Provider Collaborative is an award-winning partnership which includes NHS trusts, a community interest company and independent sector organizations, with Devon Partnership NHS Trust as the lead provider. With an extensive geography and a population of over 5.5 million, this innovative way of working at scale has transformed the mental healthcare landscape in the South West, delivering high-quality care as close to home as possible and co-produced clinical pathways that prioritize patient wellbeing and community connection.

About Novari Health

Novari Health, a VitalHub company, delivers award-winning cloud-based enterprise scale referral management, central intake (coordinated care), and wait list management software solutions that improve access to care, whilst improving the efficiency and effectiveness of healthcare organizations. Leveraging HL7, FHIR, DICOM, and other international standards, our technologies complement and integrate with a wide variety of healthcare systems (e.g., HIS, eReferral, PACS, etc.). Novari is one of the most trusted digital health solution providers. ISO 27001 and Cyber Essentials Plus certified, Novari Health is a Microsoft Partner, with software solutions hosted on Microsoft Azure’s global network of data centres.

About VitalHub

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub's comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,000 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 500 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka. For more information about VitalHub (TSX:VHI) (OTCQX:VHIBF), please visit www.vitalhub.com and LinkedIn.

Contact Information

Christian Sgro, CPA, CA, CFA
Head of IR and M&A Specialist
(365) 363-6433
[email protected]

Dan Matlow
Chief Executive Officer, Director
(416) 727-9061
[email protected]

Cautionary Statement

Certain statements contained in this news release may constitute "forward-looking information" or "financial outlook" within the meaning of applicable securities laws that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information or financial outlook. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

October 09, 2025 17:00 ET

 | Source:

Linamar Corporation

GUELPH, Ontario, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Linamar Corporation (TSX:LNR) is pleased to announce that it has entered into a definitive agreement to acquire select assets of Aludyne Incorporated’s North American operations. Aludyne is a Tier 1 automotive supplier specializing in lightweight aluminum chassis and structural technologies. The transaction, valued at $300 million USD, significantly expands Linamar’s manufacturing footprint across North America, notably in the United States.

This acquisition is highly complementary to Linamar’s existing Structures and Chassis business, adding advanced capabilities in aluminum casting, precision machining, and product design. Aludyne’s portfolio includes knuckles, subframes, control arms, and axle housings, which aligns with Linamar’s strategic focus on propulsion-agnostic structural components. Upon deal completion, these Aludyne North America facilities will be integrated into the Linamar Structures Group, part of the company’s broader Mobility Segment.

The addition of U.S.-based manufacturing assets is expected to further strengthen Linamar’s ability to support customers locally, which is increasingly important in today’s dynamic global trade environment. A diversified geographic footprint ensures resilience and flexibility in responding to evolving geopolitical and regulatory frameworks, while maintaining high standards of quality and delivery.

This transaction also supports Linamar’s Canadian operations with new collaborative business opportunities for cast and machined products, reinforcing the company’s commitment to its domestic manufacturing base. Linamar remains a strong and stable presence in Canada, with a long-standing history of innovation, investment, and partnership with key OEM customers.

Linamar has successfully executed similar integrations in the past, and this acquisition follows a proven model. Working closely with our valued customer base, Linamar has developed a long-term, sustainable business plan that ensures continuity and growth. The highly qualified and capable Aludyne teams will be a valuable addition to Linamar’s global workforce.

The transaction is expected to be accretive soon after acquisition.

Linda Hasenfratz, Executive Chair of Linamar, commented:

“We are thrilled to welcome the Aludyne teams into the Linamar family. This acquisition enhances our leadership in propulsion-agnostic, lightweight aluminum casting and machining technologies. Aludyne’s proprietary light metal casting technology offers great growth opportunity to our structural casting business and further strengthens our Mobility business.”

Jim Jarrell, CEO and President of Linamar, added:

“This is another example of how Linamar’s strong financial position, operational excellence, and history of successful integrations create new opportunities in the market. It also reinforces supply chain stability for our OEM customers. We look forward to completing the transaction and integrating Aludyne North America into our global Mobility operations.”

Eric Showalter, CEO of Aludyne, stated:

“This is a very exciting opportunity for the Aludyne North America team to join forces with a company as strong and respected as Linamar - one that deeply values its customers, shareholders, and employees. This combination positions the business for continued growth, innovation, and long-term success.”

The transaction is subject to customary regulatory approvals and is expected to close within 30 days. Linamar will fund the acquisition using available liquidity under its existing credit facilities and cash on hand.

On the transaction, National Bank Capital Markets acted as the Financial Advisor to Linamar.

Linamar Corporation (TSX:LNR) is a diversified advanced manufacturing company where the intersection of leading-edge technology and deep manufacturing expertise is creating solutions that power vehicles, motion, work and lives for the future. At the heart of Linamar is the technologies we deliver; casting, forging, metal forming, machining and assembly and fully engineered products. We serve a broad variety of industries, from our On and Off Highway Mobility business to our Agricultural and Access businesses to new areas of expansion in MedTech, Water, Power, Defense and Robotics. We proudly market our global, class leading products under the brands Linamar, Skyjack, MacDon, Salford, Bourgault and McLaren Engineering. Linamar has over 34,000 employees in 75 manufacturing locations, 17 R&D centers and 31 sales offices in 19 countries in North and South America, Europe and Asia, which generated sales of more than $10.5 billion in 2024. For more information about Linamar Corporation and its industry-leading products and services, visit www.linamar.com or follow us on our social media channels.

To the extent any forward-looking statement in this press release constitutes “future-oriented financial information” or “financial outlooks” within the meaning of applicable Canadian securities laws, such information is being provided to demonstrate the anticipated results and the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such future-oriented financial information and financial outlooks. Future-oriented financial information and financial outlooks, as with forward-looking statements generally, are, without limitation, based on the assumptions and subject to risks. The Company’s actual financial position and results of operations may differ materially from management’s current expectations. Any future-oriented financial information and financial outlooks used herein is neither audited nor reviewed. Where possible, the information has been constructed by management from available audited or audit reviewed financial statements. Where no audited or audit reviewed information has been available, additional management accounting information has been utilized to construct the financial information. The targets set forth in the future-oriented financial information, and the related assumptions, involve known and unknown risks and uncertainties that may cause actual results to differ materially. While Linamar believes there is a reasonable basis for these targets, such targets may not be met. Accordingly, do not place undue reliance on any future-oriented financial information or financial outlooks.

For further information regarding this release please contact

Linda Hasenfratz at (519) 836-7550.

TORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) senior management will host a conference call on Wednesday, November 12, 2025 at 11:00 a.m. ET to discuss the Company’s third quarter 2025 results.

Third Quarter 2025 Results Conference Call and Webcast Date:Wednesday, November 12, 2025Time:11:00 a.m. ETWebcast:www.hudbay.comDial in:1-833-752-3516 or 647-846-8185
Hudbay plans to issue a news release containing the third quarter of 2025 results before the market open on Wednesday, November 12, 2025 and post it on the Company’s website. An archived audio webcast will be available on Hudbay’s website following the call.

About Hudbay

Hudbay (TSX, NYSE: HBM) is a copper-focused critical minerals mining company with three long-life operations and a world-class pipeline of copper growth projects in tier-one mining jurisdictions of Canada, Peru and the United States.

Hudbay’s operating portfolio includes the Constancia mine in Cusco (Peru), the Snow Lake operations in Manitoba (Canada) and the Copper Mountain mine in British Columbia (Canada). Copper is the primary metal produced by the Company, which is complemented by meaningful gold production and by-product zinc, silver and molybdenum. Hudbay’s growth pipeline includes the Copper World project in Arizona (United States), the Mason project in Nevada (United States), the Llaguen project in La Libertad (Peru) and several expansion and exploration opportunities near its existing operations.

The value Hudbay creates and the impact it has is embodied in its purpose statement: “We care about our people, our communities and our planet. Hudbay provides the metals the world needs. We work sustainably, transform lives and create better futures for communities.” Hudbay’s mission is to create sustainable value and strong returns by leveraging its core strengths in community relations, focused exploration, mine development and efficient operations.

For further information, please contact:

Candace Brûlé
Vice President, Investor Relations, Financial Analysis and External Communications
(416) 814-4387
[email protected]

October 09, 2025 5:00 PM EDT | Source: ALUULA Composites Inc.
Victoria, British Columbia and Trappes, France--(Newsfile Corp. - October 9, 2025) - ALUULA Composites Inc. (TSXV: AUUA) ("ALUULA" or the "Company") and Michelin Inflatable Solutions (MIS) announced today the successful completion of the research and development phase of their collaboration, with the first commercial product set for potential release by MIS in late 2025.

Just over a year after launching a groundbreaking R&D collaboration (which was announced March 18th, 2024) ALUULA and Michelin have successfully concluded their joint research project focused on leveraging ALUULA's ultra-light, high performance, and fully recyclable composite materials in a new generation of inflatable devices designed and manufactured by MIS. With this milestone, the two companies now move into commercialization, bringing this sustainable innovation one step closer to market readiness.

Breakthrough design: stronger, fully recyclable

At the heart of this partnership lies a shared ambition: to revolutionize the construction of strong, and sustainable shelters. The project has resulted in an innovative design by Michelin Research & Technology (MRT), constructed using ALUULA's high-performance ultra-lightweight material composites. Dedicated to high-demanding applications such as Aeronautics & Space or Defense, this innovation results in structures that can reach unmatched performance compared with other inflatable technologies.

Market launch: first product by the end of 2025

MIS plans to release the first commercial product from the project by the end of 2025, and scale-up and full commercialization are anticipated in 2026.

"This is an exciting moment for us," said Anne-Frédérique SALIT, CEO of Michelin Inflatable Solutions. "By combining our advanced material assembly expertise with ALUULA's truly innovative material technology, we've created something that redefines the standard for high-performance structures. It's smart, it's sustainable, and it's exactly what the future demands."

Stronger together: innovation through collaboration

"This collaboration marks an exciting step forward," said Christophe Penot, Director of Michelin Recherche et Technique, Fribourg. "Working with innovative start-ups like ALUULA opens new avenues for breakthrough thinking. The agile and inventive nature of our R&D center has been instrumental in helping bring ALUULA's advanced materials to market quickly. By combining our engineering expertise with their pioneering composite technology, we're delivering high-performance, sustainable materials that meet the demands of the future—today."

"We're proud to see our ultra-light and durable composite materials heading toward commercialization in such a meaningful application," said Sage Berryman, CEO and President at ALUULA. "Michelin's visionary approach proves that high performance and sustainability can—and must—go hand in hand. This collaboration shows how powerful innovation can be when values align."

Performance meets planet: a new class of materials

ALUULA's composite materials are eight times stronger than steel for an equivalent weight. They are recycle-ready, made with a patented, adhesive-free manufacturing process that offers exceptional strength-to-weight ratios while being waterproof, UV-resistant, and designed for recyclability. These composite materials leverage durability and sustainability, marking a significant step forward for eco-conscious structural design.

Shaping the future of high-tech materials such as ALUULA's can be leveraged with Michelin Research & Technology's distinctive strengths in cross-functional collaboration, accelerated prototyping, and deep expertise in next-generation composite materials.

Michelin Inflatable Solutions focuses on bringing the right balance of performance to match customer needs by developing specific processes to assemble unexpected functional flexible materials. MIS is able to move efficiently from development to deployment by drawing on the industrial strength of Michelin.

This collaboration helps accelerate innovation and brings advanced inflatable materials.

Continued focus: scaling sustainability through partnerships

Both companies reaffirm their commitment to scaling the impact of next-generation materials. ALUULA will continue to expand the reach of its high-performance materials through strategic partnerships with industry leaders, such as Michelin, accelerating the path to circular product design.

About ALUULA Composites

ALUULA is an ultra-light, high performance and recycle-ready composite materials brand that enhances the performance of outdoor gear. Proudly manufactured on the Canadian west coast, ALUULA's innovation is driven by a deep understanding that equipment does not need to sacrifice performance for sustainability. ALUULA's materials are known for their unique construction capabilities and their ability to make products lighter, stronger, and more sustainable.

About Michelin

Michelin is building a world-leading manufacturer of life-changing composites and experiences. Pioneering engineered materials for more than 130 years, Michelin is uniquely positioned to make decisive contributions to human progress and to a more sustainable world. Drawing on its deep know-how in polymer composites, Michelin is constantly innovating to manufacture high-quality tires and components for critical applications in demanding fields as varied as mobility, construction, aeronautics, low-carbon energies, and healthcare. The care placed in its products and deep customer knowledge inspire Michelin to offer the finest experiences. This spans from providing data- and AI based connected solutions for professional fleets to recommending outstanding restaurants and hotels curated by the MICHELIN Guide. Headquartered in Clermont-Ferrand, France, Michelin is present in 175 countries and employs 129,800 people (www.michelin.com).

Contact Information

ALUULA Composites

Forward-Looking Statements

The information in this news release includes certain information and statements about management's view of future events, expectations, plans, and prospects that constitute forward-looking statements, including, but not limited to: the next step of commercializing a new generation of inflatable devices designed and manufactured by MIS; MIS plans to release the first commercial product from the project by the end of 2025, and scale-up and full commercialization, which MIS anticipates will be in in 2026; and the objective of revolutionizing the construction of strong, and sustainable shelters. These statements are based on assumptions subject to significant risks and uncertainties including the inherent risks of developing and commercializing new products for existing industries, the timing for commercializing these new products, the acceptance of the market for new products by potential purchasers, competition from existing and new entrants to this industry and the potential resistance of the current industry to change. Because of these risks and uncertainties and as a result of a variety of factors, performance may differ materially from those anticipated and indicated by these forward-looking statements. Although the Company believes that the expectations reflected in forward-looking statements are reasonable, many of them are out of the Company's control and it can give no assurances that the expectations of any forward-looking statement will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/269892

Carlsbad, CA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that the Company determined to cancel its previously adjourned special meeting of stockholders (the “Special Meeting”), which had been scheduled to reconvene on Friday, October 10, 2025, at 10:00 a.m. Pacific Time.

The Special Meeting was previously adjourned to, and reconvened on, September 26, 2025, but was adjourned again without any business being conducted, due to the lack of the required quorum as of the meeting time. As of today, the Company has still not received proxies that would constitute a quorum and has decided to cancel the Special Meeting and to withdraw from consideration by the Company’s stockholders the proposals set forth in the definitive proxy statement filed with the U.S. Securities and Exchange Commission on August 18, 2025.

About Palisade Bio

Palisade Bio is a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.

Investor Relations Contact

JTC Team, LLC
Jenene Thomas
908-824-0775
[email protected]